PubRank

Michael Thomas

Author PubWeight™ 164.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 2013 14.78
2 Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med 2014 9.94
3 MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003 7.90
4 PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. J Clin Oncol 2013 5.48
5 The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012 4.30
6 Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial. Lancet Oncol 2012 4.29
7 Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer. J Clin Oncol 2010 3.13
8 Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002 2.92
9 Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 2004 2.43
10 BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol Cell 2004 2.32
11 Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol 2004 2.01
12 Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer. J Clin Oncol 2011 1.88
13 Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007 1.87
14 Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol 2010 1.85
15 Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006 1.70
16 Harvesting waste thermal energy using a carbon-nanotube-based thermo-electrochemical cell. Nano Lett 2010 1.63
17 Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial. J Clin Oncol 2012 1.55
18 Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun 2002 1.54
19 HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy. Lung Cancer 2004 1.48
20 S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 2004 1.41
21 Implications of the 2013 U.S. Veterinary Workforce Study and recommendations for future actions: AVMA Workforce Advisory Group. J Am Vet Med Assoc 2013 1.39
22 Outcome of Copeland surface replacement shoulder arthroplasty. J Shoulder Elbow Surg 2005 1.38
23 The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data. J Antimicrob Chemother 2005 1.27
24 Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid Redox Signal 2007 1.24
25 Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res 2005 1.22
26 Interactive workshops increase chlamydia testing in primary care--a controlled study. Fam Pract 2008 1.19
27 What can developmental disorders tell us about the neurocomputational constraints that shape development? The case of Williams syndrome. Dev Psychopathol 2003 1.18
28 Disrupting protein NEDDylation with MLN4924 is a novel strategy to target cisplatin resistance in ovarian cancer. Clin Cancer Res 2013 1.17
29 Mechanism of ion permeation and selectivity in a voltage gated sodium channel. J Am Chem Soc 2012 1.17
30 Exploring the Williams syndrome face-processing debate: the importance of building developmental trajectories. J Child Psychol Psychiatry 2004 1.16
31 Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. Clin J Am Soc Nephrol 2010 1.12
32 Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle 2007 1.11
33 Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpoint. Immunity 2006 1.08
34 EGFR-TKI resistant non-small cell lung cancer (NSCLC): new developments and implications for future treatment. Lung Cancer 2012 1.05
35 Surgical intervention for pulmonary metastases. Dtsch Arztebl Int 2012 1.02
36 Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial. Obstet Gynecol 2007 1.01
37 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy. Eur Respir J 2011 1.00
38 Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer. Lung Cancer 2002 1.00
39 Adrenocortical dysfunction in liver disease: a systematic review. Hepatology 2012 0.99
40 Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial. Cancer 2011 0.98
41 Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis. FASEB J 2006 0.97
42 Trimodality treatment in Stage III nonsmall cell lung carcinoma: prrognostic impact of K-ras mutations after neoadjuvant therapy. Cancer 2002 0.97
43 Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-kappaB. Cancer Res 2006 0.97
44 Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies. Virchows Arch 2012 0.96
45 Bilirubin promotes de novo generation of T regulatory cells. Cell Transplant 2009 0.94
46 KRAS-mutation positive, metastatic tonsil carcinoma with cancer stem-like cell features and long-term response to gefitinib: a case report and review of the literature. J Clin Oncol 2011 0.94
47 Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma. Artif Organs 2009 0.94
48 Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer. J Thorac Oncol 2010 0.94
49 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease. BMC Pulm Med 2012 0.93
50 Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index. Fertil Steril 2008 0.93
51 Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients. Lung Cancer 2008 0.92
52 A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis. Int J Cancer 2012 0.91
53 Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients. Respir Res 2013 0.91
54 The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. Anticancer Res 2011 0.91
55 EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. Eur Respir J 2013 0.91
56 Exercise in patients with non-small cell lung cancer. Med Sci Sports Exerc 2014 0.89
57 When do we need to care about the caregiver? Supportive care needs, anxiety, and depression among informal caregivers of patients with cancer and cancer survivors. Cancer 2015 0.89
58 Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells. Int J Oncol 2007 0.88
59 Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas. Cancer Lett 2006 0.87
60 Assessment of body image in patients undergoing surgery for colorectal cancer. Int J Colorectal Dis 2009 0.87
61 Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapy. Clin Endocrinol (Oxf) 2010 0.86
62 First-line systemic treatment with gefitinib in stage IV non-small cell lung cancer. Oncol Rep 2005 0.86
63 Targeting the epidermal growth factor receptor in non-small cell lung cancer. Onkologie 2010 0.85
64 Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer 2004 0.85
65 Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer. J Thorac Oncol 2013 0.84
66 Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol. BMC Cancer 2007 0.84
67 Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study. J Thorac Oncol 2014 0.83
68 Fatal marrow emboli in a pediatric patient having posterior spinal instrumentation for scoliosis repair. Paediatr Anaesth 2006 0.83
69 Discrimination between benign, primary and secondary malignancies in lymph nodes from the head and neck utilising Raman spectroscopy and multivariate analysis. Analyst 2013 0.83
70 The European initiative for quality management in lung cancer care. Eur Respir J 2014 0.83
71 Improving the appropriateness of laboratory submissions for urinalysis from general practice. Fam Pract 2008 0.82
72 Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer. Anticancer Res 2013 0.82
73 Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer. Int J Cancer 2009 0.82
74 Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis. BMC Cancer 2014 0.81
75 Signal transduction pathways as novel therapy targets in lung cancer. Lung Cancer 2004 0.81
76 Problems of basing patient recruitment for primary care studies on routine laboratory submissions. J Clin Pathol 2007 0.81
77 Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer. J Thorac Oncol 2011 0.81
78 Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer. Clin Cancer Res 2009 0.81
79 Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability. Clin Ther 2002 0.81
80 Different approaches to relating genotype to phenotype in developmental disorders. Dev Psychobiol 2002 0.81
81 Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents. Bioorg Med Chem Lett 2009 0.81
82 COX-2 upregulation in thymomas and thymic carcinomas. Int J Cancer 2006 0.81
83 Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer. Lung Cancer 2006 0.81
84 Point of care testing is appropriate for National Health Service health check. Ann Clin Biochem 2011 0.81
85 Characteristics and outcome of patients with second primary lung cancer. Eur Respir J 2012 0.81
86 Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial. Obstet Gynecol 2010 0.80
87 Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis. Eur Respir J 2012 0.80
88 Assessment of thymidylate synthase expression in biopsy specimens and corresponding resection specimens of non-small-cell lung cancer. Histopathology 2012 0.80
89 Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer. Eur J Cardiothorac Surg 2004 0.79
90 Gene-targeted analysis of copy number variants identifies 3 novel associations with coronary heart disease traits. Circ Cardiovasc Genet 2012 0.79
91 Treatment and outcomes in patients with asthma and allergic rhinitis in the United kingdom. Int Arch Allergy Immunol 2006 0.79
92 The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP). Lung Cancer 2012 0.79
93 Physical performance and psychosocial status in lung cancer patients: results from a pilot study. Oncol Res Treat 2014 0.79
94 Comprehension of metaphor and metonymy in children with Williams syndrome. Int J Lang Commun Disord 2009 0.79
95 What have we learnt about the mechanisms of rapid water transport, ion rejection and selectivity in nanopores from molecular simulation? Small 2014 0.79
96 Indwelling bowel management system as a cause of life-threatening rectal bleeding. Case Rep Gastroenterol 2008 0.79
97 Indirect ion selective electrode methods potentially overestimate peritoneal dialysate sodium losses. Ther Apher Dial 2013 0.79
98 Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer. Invest New Drugs 2013 0.78
99 Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy. Cancer Chemother Pharmacol 2011 0.78
100 Pillars Article: Flow Cytometric Studies of Oxidative Product Formation by Neutrophils: A Graded Response to Membrane Stimulation. J. Immunol. 1983. 130: 1910-1917. J Immunol 2016 0.78
101 Leptospira infections in freshwater fish in Morogoro Tanzania: a hidden public health threat. Tanzan J Health Res 2014 0.78
102 Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer. Respiration 2013 0.78
103 Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer. Eur Respir J 2013 0.78
104 Surface modifications by gas plasma control osteogenic differentiation of MC3T3-E1 cells. Acta Biomater 2012 0.78
105 Expression and mutation analysis of EGFR, c-KIT, and β-catenin in pulmonary blastoma. J Clin Pathol 2011 0.77
106 Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life. Lung Cancer 2004 0.77
107 Using cell transplantation to investigate genes involved in aging. Mech Ageing Dev 2003 0.77
108 One-port video assisted laparoscopic kidney biopsy in standing steers. Res Vet Sci 2008 0.77
109 Prevalence of undiagnosed cardiovascular risk factors and 10-year CVD risk in male steel industry workers. J Occup Environ Med 2014 0.77
110 BESS/BOA Patient Care Pathways: Traumatic anterior shoulder instability. Shoulder Elbow 2015 0.77
111 Subacromial shoulder pain. Shoulder Elbow 2015 0.77
112 Blockade of p38 MAPK inhibits chronic allograft vasculopathy. Transplantation 2008 0.77
113 Assessing patient-caregiver communication in cancer--a psychometric validation of the Cancer Communication Assessment Tool (CCAT-PF) in a German sample. Support Care Cancer 2014 0.77
114 In vivo glenohumeral analysis using 3D MRI models and a flexible software tool: feasibility and precision. J Magn Reson Imaging 2008 0.76
115 Love is... an abstract word: the influence of lexical semantics on verbal short-term memory in Williams syndrome. Cortex 2005 0.76
116 Molecular determinants of response to RTK-targeting agents in nonsmall cell lung cancer. Int J Cancer 2006 0.76
117 Gender disparity and MELD in liver transplantation. J Hepatol 2011 0.76
118 An experienced physiotherapist prescribing and administering corticosteroid and local anaesthetic injections to the shoulder in an Australian orthopaedic service, a non-inferiority randomised controlled trial and economic analysis: study protocol for a randomised controlled trial. Trials 2014 0.76
119 Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat Med 2016 0.76
120 Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidate. J Med Chem 2014 0.76
121 [The boundaries of curation]. Onkologie 2010 0.76
122 Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model. Respir Res 2005 0.75
123 Frozen Shoulder. Shoulder Elbow 2015 0.75
124 Glenohumeral osteoarthritis. Shoulder Elbow 2016 0.75
125 Importance of self-awareness in development of veterinary leaders. J Am Vet Med Assoc 2015 0.75
126 Adrenocortical cell proliferation in a cell transplantation model: the role of SV40 T antigen. Endocr Res 2002 0.75
127 [Local and systemic therapy of non-small cell lung carcinoma (NSCLC)]. Onkologie 2010 0.75
128 [44th Congress of the German Pneumology Society, 26-9 March 2003 in Munich. News in Pneumology--section events of the GPS]. Pneumologie 2003 0.75
129 [Therapy in non-small-cell lung carcinoma (NSCLC) in local advanced stage (inoperable IIIA/IIIB)]. Onkologie 2006 0.75
130 784: CONTINUOUS LIDOCAINE INFUSION AS ADJUNCTIVE ANALGESIA IN INTENSIVE CARE UNIT PATIENTS. Crit Care Med 2016 0.75
131 Bilirubin rinse of the graft ameliorates ischemia reperfusion injury in heart transplantation. Transpl Int 2014 0.75
132 Opening up in the classroom: effects of expressive writing on graduate school entrance exam performance. Emotion 2011 0.75
133 Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR- Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE). Oncol Res Treat 2016 0.75
134 [Graft-versus-host-like flexural eruption after autologous stem cell transplantation]. J Dtsch Dermatol Ges 2003 0.75
135 Are bilateral axillary incisions needed or is just a single unilateral incision sufficient for robotic-assisted total thyroidectomy? Arch Surg 2011 0.75
136 [Thoracic oncology - optimization through integrated approaches, quality assurance, and molecular biology. Forward]. Onkologie 2012 0.75
137 Environmental factors responsible for the incidence of antibiotic resistance genes in pristine Crassostrea virginica reefs. Mar Pollut Bull 2012 0.75
138 Taking ACTION to establish direct costs and outcomes of treating advanced non-small cell lung cancer in routine clinical practice. Lung Cancer 2004 0.75
139 Molecular Determinants for Substrate Interactions with the Glycine Transporter GlyT2. ACS Chem Neurosci 2017 0.75
140 [How can patient care be improved? Goal: compulsory standards for lung cancer (interview by Dr. Jochen Aumiller)]. MMW Fortschr Med 2009 0.75
141 Hepascore and hyaluronic acid as markers of fibrosis in liver disease of mixed aetiology. Eur J Gastroenterol Hepatol 2015 0.75
142 Symptoms and Needs of Head and Neck Cancer Patients at Diagnosis of Incurability - Prevalences, Clinical Implications, and Feasibility of a Prospective Longitudinal Multicenter Cohort Study. Oncol Res Treat 2016 0.75
143 Supervised short-term nutrition and exercise promotes weight loss in overweight and obese patients with polycystic ovary syndrome. Fertil Steril 2008 0.75
144 Competitive Energy and Electron Transfer in b-Functionalized Free-Base porphyrin-Zinc Porphyrin Dimer Axially Coordinated to C60. Chemistry 2017 0.75
145 How will health-care organizations meet venous thromboembolism targets? Br J Hosp Med (Lond) 2011 0.75
146 [Structures and ways of decision making in thoracic oncology: foreword]. Onkologie 2013 0.75
147 Ultrafast charge separation in triphenylamine-BODIPY derived triads carrying centrally positioned, highly electron deficient, dicyanoquinodimethane or tetracyanobutadiene acceptors. Chemistry 2017 0.75
148 [Clinic for Radiation Therapy and Internal Medicine Oncology, Pius-Hospital Oldenburg, Germany]. Onkologie 2011 0.75
149 [Foreword]. Onkologie 2008 0.75